SAT KARTAR LIFE LIMITED vs SUN PHARMACEUTICAL IND L
A side-by-side comparison of SAT KARTAR LIFE LIMITED (SATKARTAR) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
SAT KARTAR LIFE LIMITED vs SUN PHARMACEUTICAL IND L are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
- Valuation22
- Profitability22
- Growth20
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
SATKARTAR takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
SUNPHARMA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has reduced debt.", "Company is almost debt free.", "Company has a good return on equity (ROE) track record: 3 Years ROE 33.0%"]
- − ["Working capital days have increased from 28.3 days to 60.9 days"]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.